期刊
JOURNAL OF GENERAL VIROLOGY
卷 93, 期 -, 页码 980-986出版社
SOC GENERAL MICROBIOLOGY
DOI: 10.1099/vir.0.038679-0
关键词
-
资金
- Interdisciplinary Centre for Human and Avian Influenza Research (ICHAIR)
- BBSRC ISPG
- BBSRC [BBSRC BB/FOF/324]
- BBSRC [BBS/E/D/20241866] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BBS/E/D/20241866] Funding Source: researchfish
The emergence of drug-resistant strains of influenza virus has catalysed a search for new antiviral agents to supplement or replace existing drugs. Following the success of the human immunodeficiency virus entry blocker Enfuvirtide, there has been a resurgence of interest in peptide-based antivirals. In this paper, we report on the discovery of a novel family of peptides (FluPep, FP) that function as inhibitors of influenza A virus infection. The prototype peptide (FP1, also known as Tkip) interacts with haemagglutinin and inhibits the binding of the virus to cell membranes. Using a plaque-reduction assay, we have demonstrated that a variety of influenza A virus subtypes (including H1N1, H3N2 and H5N1) are inhibited by FluPep and its derivatives at nanomolar concentrations. By truncating FluPep we have identified a minimal sequence of 6 aa that binds to haemagglutinin and inhibits infection. Using a mouse model of intranasal influenza virus infection, we observed potent inhibition of virus infection when peptide is given at the time of virus administration. These data indicate that FluPep is a highly effective anti-influenza agent with the potential to translate to the clinic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据